Organovo bio-printed human liver tissue

[Updated 5:58 p.m. PT. See below.] Organovo, a company developing technology to 3D print human tissue, announced two months ago that its dwindling cash is leading it to explore options that include merging with another firm. The San Diego biotech now has an offer from a familiar face close to home.

Viscient Biosciences, a seven-person biotech startup also based in San Diego, announced Wednesday that it has submitted a merger proposal to the Organovo (NASDAQ: ONVO) board of directors. The two companies are well-acquainted. They’ve been working together on potential treatments for the fatty liver disease nonalcoholic Read more »